Stock listing

NASDAQ:MPLT MapLight Therapeutics, Inc. Stock

Home listing (NASDAQ) of MapLight Therapeutics, Inc.

Follow MapLight Therapeutics, Inc. into a list and get an email when it puts out news.

Share price · NASDAQ:MPLT

$6.78 USD -0.80 (-10.6%)

Close on Nov 2, 2026

Past year -59.9% · daily closes, Nov 3, 2025 – Nov 2, 2026, adjusted for splits
Day range
$6.77 – $7.67 USDNov 2, 2026
Volume
245,490 sharesNov 2, 2026
Market cap
$358.3M USDAt the close on Nov 2, 2026 · price × 52.85M shares outstanding
52-week range
$6.77 – $40.43 USDLowest and highest trades, Nov 3, 2025 – Nov 2, 2026
Traded on an average day
$5.65M USDMedian day 451,800 shares · last 3 months, Aug 3, 2026 – Nov 2, 2026
MapLight Therapeutics, Inc. logo

Prices by listing

ListingLastChangeVolumeOpenHighLowPrevious closePrice from
NASDAQ:MPLT · Home$6.78 USD-0.80 (-10.6%)245,490$7.65$7.665$6.765$7.58Close on Nov 2, 2026

Daily closes

Last 3 months, Aug 3, 2026 – Nov 2, 2026 · NASDAQ:MPLT · USD, adjusted for splits

DayCloseChange%OpenHighLowVolume
$6.78-0.80-10.6%$7.65$7.665$6.765245,490
$7.58-0.14-1.8%$7.70$7.81$7.44394,984
$7.72-0.26-3.3%$8.08$8.192$7.65156,676
$7.98-0.19-2.3%$8.09$8.135$7.81365,932
$8.17+0.51+6.7%$7.66$8.25$7.50384,829
$7.66-0.31-3.9%$7.98$8.34$7.58252,481
$7.97-0.28-3.4%$8.18$8.285$7.84305,300
$8.25+0.09+1.1%$8.16$8.485$7.96349,500
$8.16-0.08-1.0%$8.21$8.58$7.995343,800
$8.24+0.24+3.0%$8.33$8.55$8.03355,000
$8.00+0.30+3.9%$7.73$8.07$7.66278,700
$7.70-0.32-4.0%$8.10$8.10$7.56359,100
$8.02+0.21+2.7%$7.84$8.43$7.743658,400
$7.81-0.065-0.8%$7.78$8.075$7.46450,900
$7.875-0.725-8.4%$8.60$8.60$7.85301,700
$8.60-0.23-2.6%$8.82$8.90$8.48485,200
$8.83-0.32-3.5%$9.15$9.415$8.70495,400
$9.15-0.21-2.2%$9.30$9.33$9.00217,600
$9.36-0.33-3.4%$9.62$9.88$9.30275,200
$9.69+0.415+4.5%$9.24$9.97$8.92495,600
$9.275-0.545-5.5%$9.80$9.80$9.19262,000
$9.82+0.19+2.0%$9.70$10.17$9.43565,700
$9.63-0.56-5.5%$10.16$10.17$9.57432,200
$10.19+0.04+0.4%$10.45$10.51$9.93303,300
$10.15-0.30-2.9%$10.64$10.64$10.12408,300
$10.45-0.01-0.1%$10.39$10.59$10.15251,600
$10.46-0.30-2.8%$10.81$10.87$10.39317,500
$10.76-0.01-0.1%$10.60$10.86$10.16341,800
$10.77-0.09-0.8%$10.89$10.93$10.13539,000
$10.86-0.04-0.4%$11.02$11.28$10.64411,300
$10.90-0.02-0.2%$11.06$11.28$10.78542,900
$10.92-0.40-3.5%$11.21$11.21$10.511,832,900
$11.32-0.08-0.7%$11.57$11.73$11.13545,900
$11.40-0.68-5.6%$12.06$12.16$11.35613,900
$12.08-1.07-8.1%$13.10$13.11$12.05402,300
$13.15+0.15+1.2%$13.08$13.45$12.66327,600
$13.00-0.785-5.7%$13.88$14.14$12.80340,200
$13.79+0.075+0.5%$13.49$14.04$13.19490,300
$13.71-0.24-1.7%$13.95$14.22$13.51500,200
$13.95+0.18+1.3%$13.49$14.09$13.19522,000
$13.77+0.63+4.8%$13.03$14.14$13.00550,900
$13.14+0.08+0.6%$13.20$13.45$12.96863,500
$13.06-0.25-1.9%$13.33$13.94$12.82937,700
$13.31+0.34+2.6%$12.99$13.93$12.32580,700
$12.97+0.37+2.9%$12.59$13.07$12.12440,600
$12.60+0.06+0.5%$12.65$12.84$12.20375,100
$12.54-0.32-2.5%$12.87$13.24$12.50741,500
$12.86+0.32+2.6%$12.47$12.95$11.71910,000
$12.54+1.18+10.4%$11.47$12.74$11.35703,481
$11.36+0.15+1.3%$11.21$11.44$10.51563,455
$11.21-0.02-0.2%$11.35$11.61$11.07435,400
$11.23-0.92-7.6%$12.07$12.21$10.96555,300
$12.15+0.33+2.8%$12.11$12.32$11.69896,400
$11.82+0.575+5.1%$11.20$11.93$11.08547,800
$11.25-0.505-4.3%$11.76$11.79$10.96620,500
$11.75+0.17+1.5%$12.04$12.25$11.23451,800
$11.58+0.20+1.8%$11.92$12.32$11.51501,200
$11.38-0.60-5.0%$12.15$12.32$11.33478,300
$11.98-0.20-1.6%$12.16$12.29$11.59359,000
$12.18+0.01+0.1%$11.06$12.52$10.84552,200
$12.17-1.11-8.4%$13.28$13.61$12.09432,500
$13.28+0.36+2.8%$12.76$13.74$12.71476,700
$12.92-0.02-0.2%$13.32$13.39$12.76886,900
$12.94+0.39+3.1%$12.57$13.03$12.37847,600
$12.55-0.47-3.6%$12.85$13.14$12.08999,900
Ticker
NASDAQ:MPLT
Asset type
Stock
Sector
Health care
Industry
Biotechnology
Exchange
NASDAQ
Currency
USD

What changed lately

Latest news

All MapLight Therapeutics, Inc. news

Financings

  • Private placement of common stock and pre-funded warrants

    Aug 13, 2026

    Announced: about US$150M · US$11.38 a share · Morgan Stanley +3

    Dealers: Morgan Stanley, Jefferies, Leerink Partners, Stifel

    Use of proceeds: Advance ML-007C-MA, including the VISTA Phase 2 and ZEPHYR-2 Phase 3 studies, plus working capital and general corporate purposes

    Announced Aug 13, 2026

Read by 6ix AI from the company's releases

Decks

MapLight Therapeutics, Inc. on 6ix

Sector
Health care
Industry
Biotechnology
News releases
14 in the last 12 months · 16 in all · newest Oct 6, 2026 · oldest 2025
Decks
7 decks · latest Aug 13, 2026

Where MapLight Therapeutics, Inc. is listed

ListingExchangeCountryCurrency
NASDAQ:MPLT · Home listing · This pageNASDAQUnited StatesUSD
BOATS:MPLTBOATSUnited StatesUSD

Log in to ask 6ix AI your own questions about MapLight Therapeutics, Inc.